DOCSLIB.ORG

Metastatic Squamous Cell Carcinoma Metastatic Squamous Cell Carcinoma

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Metastatic Squamous Cell Carcinoma Metastatic Squamous Cell Carcinoma Volume 34 JAOCDJournalJournal OfOf TheThe AmericanAmerican OsteopathicOsteopathic CollegeCollege OfOf DermatologyDermatology Metastatic Squamous Cell Carcinoma Updated Staging Guidelines and Prognostic Factors for “High-risk” SCC Also in this issue: Delineating the Perforating Dermatoses A Rare Case of Cogan’s Syndrome with Cutaneous Findings Rhomboid Flaps and Their Modern Modifications last modified on February 17, 2016 8:09 AM JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 1 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY 2015-2016 AOCD OFFICERS PRESIDENT Alpesh Desai, DO, FAOCD PRESIDENT-ELECT Karthik Krishnamurthy, DO, FAOCD FIRST VICE-PRESIDENT Daniel Ladd, DO, FAOCD SECOND VICE-PRESIDENT John P. Minni, DO, FAOCD THIRD VICE-PRESIDENT Reagan Anderson, DO, FAOCD Editor-in-Chief SECRETARY-TREASURER Karthik Krishnamurthy, DO Steven Grekin, DO, FAOCD TRUSTEES Danica Alexander, DO, FAOCD (2015-2018) Michael Whitworth, DO, FAOCD (2013-2016) Tracy Favreau, DO, FAOCD (2013-2016) David Cleaver, DO, FAOCD (2014-2017) Sponsors: Amy Spizuoco, DO, FAOCD (2014-2017) Peter Saitta, DO, FAOCD (2015-2018) AuroraDx Immediate Past-President Ranbaxy Rick Lin, DO, FAOCD EEC Representatives Valeant James Bernard, DO, FAOCD Michael Scott, DO, FAOCD Finance Committee Representative Donald Tillman, DO, FAOCD AOBD Representative Michael J. Scott, DO, FAOCD Executive Director Marsha A. Wise, BS AOCD • 2902 N. Baltimore St. • Kirksville, MO 63501 800-449-2623 • FAX: 660-627-2623 • www.aocd.org COPYRIGHT AND PERMISSION: Written permission must be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of more than half a page, tables or figures. Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgment of the original source, and a payment of $15 per page, table or figure of reproduced material. Permission fees are waived for authors wishing to reproduce their own articles. Request for permission should be directed to JAOCD c/o AOCD, PO Box 7525, Kirksville, MO 63501. Copyright © 2003 by the Journal of the American Osteopathic College of Dermatology Print and layout by: S&S Printing and Graphics LLC, 701 N. Marion St., Kirksville, MO 63501 Copy editing by: Julia Layton, Freelance Writing and Editing Page 2 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Table of Contents Volume 34 JAOCD Editors ............................................................................................................................................................................................ 4 Letter from the Editor-in-Chief ................................................................................................................................................................... 5 Letter from the President .............................................................................................................................................................................. 6 Letter from the Executive Director ............................................................................................................................................................... 7 FEATURE ARTICLE: A Rare Case of Metastatic Squamous Cell Carcinoma: A Case Presentation and Discussion of Updated Staging Guidelines and Prognostic Factors .......................................................................................................................................................................................12 Steven Brandon Nickle, DO, Nicole Arnold, DO, J Ryan Jackson, DO, Tracy Favreau, DO, FAOCD EDITOR’S PICKS: Review of Rhomboid Flaps and Their Modern Modifications ....................................................................................................................16 Alexandra Grammenos, MS, Ana M. Rivas, BS, Jacqueline A. Thomas, DO, David L. Thomas, MD, JD, EdD Delineating the Perforating Dermatoses: Case Reports and a Review of the Literature .............................................................................20 Richard Limbert, DO, Rachel White, BA, Richard Miller, DO, FAOCD Cogan’s Syndrome with Cutaneous Findings: A Case Report and Review of Dermatologic Manifestations .............................................25 Khasha Touloei, DO, Emily Tongdee, BS, Brittany Smirnov, DO, Tracy Favreau, DO, Leeor Porges, DO ORIGINAL ARTICLES AND CASE REPORTS: Cutaneous Adenosquamous Carcinoma: A Case Study and Literature Review ..........................................................................................30 Mayha Patel, DO, Anne Nguyen, BS, David Horowitz, DO, FAOCD, Paul Shitabata, MD Bacterial Pseudomycoses of the Skin: A Case Report .................................................................................................................................32 Robert Lin, DO, Alpesh Desai, DO, FAOCD Favre-Racouchot Syndrome in a Unilateral, Perioral Distribution Associated with Tobacco Use: A Case Report and Review ..................34 Mitchell R. Manway, DO, Joseph M. Dyer, DO, Joshua D. Gapp, MD, Melinda F. Greenfield, DO Lymphadenopathic Form of Endemic Kaposi Sarcoma in an HIV-negative Gambian Male ....................................................................36 Eugene Sanik, DO, Ryan Schuering, BS, Marcus B. Goodman, DO, FAOCD Coexisting confluent and reticulated papillomatosis and terra firma-forme dermatosis ..............................................................................40 Claire Otteni, BA, Laura F. Sandoval, DO, Jonathan S. Crane, DO, FAOCD A Case of Pili Annulati Following Resolution of Alopecia Areata .............................................................................................................42 Karan Lal, BS, Charlotte Noorollah, DO Two Cases of Pediatric Acral Cutaneous Calcinosis with Transepidermal Elimination Presenting as Skin-colored Papules .....................44 Gabriela Maloney, DO, Rohini Chennuri, MD, Patricia Dymek, MD, Marylee Braniecki, MD Recurrent Basal Cell Carcinoma with Perineural Invasion: A Case Report and Review .............................................................................46 Shana Rissmiller, DO, Alecia Folkes, MS, Indira Krishnarao, MD Atypical presentation of Sézary Syndrome with CD4+/CD7+/CD26- T-cells and marked epidermotropism: A case report and literature review ..............................................................................................................................................................49 Gabriela Maloney, DO, Sujata Gaitode, MD, Igor Altman, MD, Marylee Braniecki, MD A Rare Case of Tumid Lupus Erythematosus Coexisting with Systemic Lupus Erythematosus: A Case Presentation and Discussion ....52 Jennifer Moscoso Conde, DO, Simona Bartos, MPH, John Howard, DO, Jacqueline Thomas, DO, FAOCD A Vesiculobullous Eruption Following Solid Organ Transplantation .........................................................................................................54 Nadine George, DO, Ann Reed, DO, Frank Don, DO, FAOCD, Stanley Skopit, DO, MSE, FAOCD A rare case of verrucous psoriasis in young female: A case report and review of clinicohistologic presentation and variable therapeutic response .......................................................................................................................................................................................................56 John Moesch, BA, Jessica Mercer, MD, Jennifer B. Sissom, PA-C, Jonathan S. Weiss, MD JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 3 Editor-In-Chief Founding Editor Assistant Editor Karthik Krishnamurthy, DO Jay Gottleib, DO Julia Layton, MFA Associate Editors Derrick Adams, DO Aaron Bruce, DO Jonathan Crane, DO Peter Saitta, DO Michael Scott, DO Red Bluff, CA Bozeman, MT Wilmington, NC Brooklyn, NY Seattle, WA Editorial Board Sami Abbasi, DO Marcus Goodman, DO Scott Lim, DO Andrew Racette, DO Brownstown, MI Roswell, GA Erie, PA Phoenix, AZ Brett Bender, DO Melinda Greenfield, DO Chava Lustig, DO Richard Rudnicki, DO Farmington Hills, MI Albany, GA Weston, FL Mesquite, TX Ryan Carlson, DO Denise Guevara, DO Jere Mammino, DO Amara Sayed, DO Hilliard, OH Weston, FL Winter Springs, FL San Marcos, TX Igor Chaplik, DO Andrew Hanly, MD John Minni, DO Joseph Brant Schneider, DO Aventura, FL Miami, FL Port St. Lucie, FL Shawnee Mission, KS Michael P. Conroy, MD Joel Harris, DO Tony Nakhla, DO Gregg Severs, DO Columbus, OH Madison Heights, MI Orange County, CA Scranton, PA John Coppola, DO Heather Higgins, DO Navid Nami, DO Sean Stephenson, DO Ormond Beach, FL Troy, MI Newport Beach, CA Troy, MI Matthew Elias, DO David Horowitz, DO Jon Keeling, DO Jacqueline Thomas, DO Lighthouse Point, FL Torrence, CA Lexington, KY Fort Lauderdale, FL Merrick Elias, DO Mark Lebwohl, MD Dimitria Papadopoulos, DO Jim Towry, DO Delray Beach, FL New York, NY Bellmore, NY Ocala, FL Michelle Foley, DO Angela Leo, DO John Perrotto, DO Scott Wickless, DO Ormond Beach, FL New York, NY West Palm Beach, FL Dallas, TX Page 4 JAOCD EDITORS LETTER FROM THE EDITOR-IN-CHIEF Karthik Krishnamurthy, DO, FAOCD Editor-in-Chief Dear Readership, Medscape recently published its 2015 “Why Most Doctors Get Sued” report. As I clicked on the link in my email, I held my breath in anticipation of a report confirming what I already knew: Dermatologists get sued more than other specialties. As the slideshow loaded, I reviewed the anatomy of Erb’s
Load more

Recommended publications
  • Oral Lichen Planus: a Case Report and Review of Literature
    Journal of the American Osteopathic College of Dermatology Volume 10, Number 1 SPONSORS: ',/"!,0!4(/,/'9,!"/2!4/29s-%$)#)3 March 2008 34)%&%,,!"/2!4/2)%3s#/,,!'%.%8 www.aocd.org Journal of the American Osteopathic College of Dermatology 2007-2008 Officers President: Jay Gottlieb, DO President Elect: Donald Tillman, DO Journal of the First Vice President: Marc Epstein, DO Second Vice President: Leslie Kramer, DO Third Vice President: Bradley Glick, DO American Secretary-Treasurer: Jere Mammino, DO (2007-2010) Immediate Past President: Bill Way, DO Trustees: James Towry, DO (2006-2008) Osteopathic Mark Kuriata, DO (2007-2010) Karen Neubauer, DO (2006-2008) College of David Grice, DO (2007-2010) Dermatology Sponsors: Global Pathology Laboratory Stiefel Laboratories Editors +BZ4(PUUMJFC %0 '0$00 Medicis 4UBOMFZ&4LPQJU %0 '"0$% CollaGenex +BNFT2%FM3PTTP %0 '"0$% Editorial Review Board 3POBME.JMMFS %0 JAOCD &VHFOF$POUF %0 Founding Sponsor &WBOHFMPT1PVMPT .% A0$%t&*MMJOPJTt,JSLTWJMMF .0 4UFQIFO1VSDFMM %0 t'"9 %BSSFM3JHFM .% wwwBPDEPSg 3PCFSU4DIXBS[F %0 COPYRIGHT AND PERMISSION: written permission must "OESFX)BOMZ .% be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of .JDIBFM4DPUU %0 more than half page, tables or figurFT Permissions are $JOEZ)PGGNBO %0 normally granted contingent upon similar permission from $IBSMFT)VHIFT %0 the author(s), inclusion of acknowledgement of the original source, and a payment of per page, table or figure of #JMM8BZ %0 reproduced matFSJBMPermission fees
    [Show full text]
  • Optimizing Breast Reconstruction After Mastectomy University of Antwerp Faculty of Medicine and Health Sciences
    Optimizing breast reconstruction after mastectomy mastectomy after reconstruction Optimizing breast Filip Thiessen University of Antwerp Faculty of Medicine and Health Sciences Optimizing breast reconstruction after mastectomy The use of dynamic infrared thermography Filip THIESSEN 2020 Antwerp, 2020 Thesis submitted in fulfilment of Promoters: Prof. dr. Wiebren Tjalma the requirements for the degree of Prof. dr. Gunther Steenackers Doctor in Medical Sciences at the Prof. dr. Guy Hubens University of Antwerp Co-promoter: Prof. dr. Veronique Verhoeven University of Antwerp Faculty of Medicine and Health Sciences Optimizing breast reconstruction after mastectomy: The use of dynamic infrared thermography Optimaliseren van borstreconstructies na mastectomie: Het gebruik van dynamic infrared thermography Thesis submitted in fulfilment of the requirements for the degree of Doctor in Medical Sciences at the University of Antwerp to be defended by Filip THIESSEN Proefschrift voorgelegd tot het behalen van de graad van doctor in de Medische Wetenschappen aan de Universiteit Antwerpen te verdedigen door Antwerpen, 2020 Promotoren: Prof. dr. Wiebren Tjalma Prof. dr. Gunther Steenackers Prof. dr. Guy Hubens Begeleider: Prof. dr. Veronique Verhoeven Promotoren Prof. dr. Wiebren Tjalma Prof. dr. Gunther Steenackers Prof. dr. Guy Hubens Begeleider Prof. dr. Veronique Verhoeven Members of the jury Internal Prof. dr. Jeroen Hendriks Prof. dr. Manon Huizing Prof. dr. Wiebren Tjalma Prof. dr. Gunther Steenackers Prof. dr. Guy Hubens External Prof. dr. Emiel Rutgers Prof. dr. Assaf Zeltzer © Filip Thiessen Optimizing breast reconstruction after mastectomy: The use of dynamic infrared thermography / Filip Thiessen Faculteit Geneeskunde, Universiteit Antwerpen, Antwerpen 2020 Thesis Universiteit Antwerpen – with summary in Dutch Lay-out and cover : Dirk De Weerdt (www.ddwdesign.be) Cover figure: Cold challenge to bilateral DIEP in skin sparing mastectomy (top), rapid and overall rewarming of the skin islands of the DIEP flap (bottom).
    [Show full text]
  • Thin Anterolateral Thigh Perforator Flaps: Minimizing the Partial Necrosis Rate
    Extremity/Lymphedema Original Article The perforator-centralizing technique for super- thin anterolateral thigh perforator flaps: Minimizing the partial necrosis rate Young Chul Suh, Na Rim Kim, Dai Won Jun, Jung Ho Lee, Young Jin Kim Department of Plastic and Reconstructive Surgery, Bucheon St. Mary Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea Background Despite the wide demand for thin flaps for various types of extremity recon- Correspondence: Young Chul Suh struction, the thin elevation technique for anterolateral thigh (ALT) flaps is not very popular Department of Plastic and Reconstructive Surgery, Bucheon St. because of its technical difficulty and safety concerns. This study proposes a novel perforator- Mary Hospital, College of Medicine, centralizing technique for super-thin ALT flaps and analyzes its effects in comparison with a The Catholic University of Korea, 327 skewed-perforator group. Sosa-ro, Wonmi-gu, Bucheon 14647, Methods From June 2018 to January 2020, 41 patients who required coverage of various Korea Tel: +82-32-340-2095 types of defects with a single perforator-based super-thin ALT free flap were enrolled. The in- Fax: +82-32-340-7227 cidence of partial necrosis and proportion of the necrotic area were analyzed on postopera- E-mail: [email protected] tive day 20 according to the location of superficial penetrating perforators along the flap. The centralized-perforator group was defined as having a perforator anchored to the middle third of the x- and y-axes of the flap, while the skewed-perforator group was defined as having a perforator anchored outside of the middle third of the x- and y-axes of the flap.
    [Show full text]
  • Burn Contracture Surgery
    Burn Contracture Surgery Stuart Watson Canniesburn Unit Glasgow Royal Infirmary Glasgow United Kingdom [email protected] 1 Table of Contents Prevention of Contractures ................................................................................................. 4 Contracture Definitions ....................................................................................................... 4 Timing of Contracture Surgery: Indications ....................................................................... 5 Urgent ............................................................................................................................. 5 Early ................................................................................................................................ 5 Late ................................................................................................................................. 5 General Principles and Technical Tips ............................................................................... 6 Approach to Contracture Surgery ....................................................................................... 8 Split Skin Grafts .................................................................................................................. 8 Full Thickness Grafts .......................................................................................................... 9 Dermal Substitutes .............................................................................................................
    [Show full text]
  • Pilonidal Disease
    Pilonidal Disease What is pilonidal disease and what causes it? Pilonidal disease is a chronic infection of the skin in the region of the buttock crease (Figure 1). The condition results from a reaction to hairs embedded in the skin, commonly occurring in the cleft between the buttocks. The disease is more common in men than women and frequently occurs between puberty and age 40. It is also common in obese people and those with thick, stiff body hair. Figure 1: Pilonidal disease is a chronic skin infection in the buttock crease area. Two small openings are shown (A). What are the symptoms? Symptoms vary from a small dimple to a large painful mass. Often the area will drain fluid that may be clear, cloudy or bloody. With infection, the area becomes red, tender, and the drainage (pus) will have a foul odor. The infection may also cause fever, malaise, or nausea. There are several common patterns of this disease. Nearly all patients have an episode of an acute abscess (the area is swollen, tender, and may drain pus). After the abscess resolves, either by itself or with medical assistance, many patients develop a pilonidal sinus. The sinus is a cavity below the skin surface that connects to the surface with one or more small openings or tracts. Although a few of these sinus tracts may resolve without therapy, most patients need a small operation to eliminate them. A small number of patients develop recurrent infections and inflammation of these sinus tracts. The chronic disease causes episodes of swelling, pain, and drainage.
    [Show full text]
  • Triamcinolone Acetonide Cream USP, 0.025%, 0.1%, 0.5% for Dermatologic Use Only Not for Ophthalmic Use Rx Only
    TRIAMCINOLONE ACETONIDE- triamcinolone acetonide cream Padagis Israel Pharmaceuticals Ltd ---------- Triamcinolone Acetonide Cream USP, 0.025%, 0.1%, 0.5% For Dermatologic Use Only Not For Ophthalmic Use Rx Only DESCRIPTION The topical corticosteroids constitute a class of primarily synthetic steroids used as anti- inflammatory and anti-pruritic agents. Triamcinolone acetonide is designated chemically as pregna-1,4-diene-3,20-dione,9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene) bis (oxy)]-,(11ß,16α)-. C24H31FO6, and M.W. of 434.51; CAS Reg. No. 76-25-5. Each gram of 0.025%, 0.1% and 0.5% Triamcinolone Acetonide Cream USP contains 0.25 mg, 1 mg, or 5 mg triamcinolone acetonide respectively, in a washable cream base of cetyl alcohol, cetyl esters wax, glycerin, glyceryl monostearate, isopropyl palmitate, polysorbate-60, propylene glycol, purified water, sorbic acid, and sorbitan monostearate. CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. Pharmacokinetics - The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids.
    [Show full text]
  • Summary of Product Characteristics
    Health Products Regulatory Authority Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Audaval 0.1% Ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of ointment contains 1 mg of betamethasone (0.1% w/w) as valerate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Ointment Opaque ointment. 4 CLINICAL PARTICULARS 4.1 Therapeutic Indications Audaval preparations are indicated for the treatment of: eczema in children over 1 year elderly and adults; including atopic and discoid eczemas; prurigo nodularis; psoriasis (excluding widespread plaque psoriasis); neurodermatoses, including lichen simplex, lichen planus; seborrhoeic dermatitis; contact sensitivity reactions; discoid lupus erythematosus and they may be used as an adjunct to systemic steroid therapy in generalised erythroderma. In general, ointment preparations are particularly appropriate for dry, lichenified or scaly skin conditions whereas a cream preparation may be more suitable in the case of moist or weeping lesions. 4.2 Posology and method of administration For topical use only. If no improvement is seen after two to four weeks, the diagnosis should be reconsidered and specialist referral may be necessary. Adults, adolescents and the elderly A small quantity of Audaval should be applied to the affected area one to three times daily as directed by physician until improvement occurs. It may then be possible to maintain improvement by applying once a day, or even less often, or by using the appropriate ready diluted (1 in 4) preparation, Audaval RD 0.025% Ointment. Allow adequate time for absorption after each application before applying an emollient. If no improvement is seen within two to four weeks, reassessment of the diagnosis, or referral, may be necessary.
    [Show full text]
  • St John's Institute of Dermatology
    St John’s Institute of Dermatology Topical steroids This leaflet explains more about topical steroids and how they are used to treat a variety of skin conditions. If you have any questions or concerns, please speak to a doctor or nurse caring for you. What are topical corticosteroids and how do they work? Topical corticosteroids are steroids that are applied onto the skin and are used to treat a variety of skin conditions. The type of steroid found in these medicines is similar to those produced naturally in the body and they work by reducing inflammation within the skin, making it less red and itchy. What are the different strengths of topical corticosteroids? Topical steroids come in a number of different strengths. It is therefore very important that you follow the advice of your doctor or specialist nurse and apply the correct strength of steroid to a given area of the body. The strengths of the most commonly prescribed topical steroids in the UK are listed in the table below. Table 1 - strengths of commonly prescribed topical steroids Strength Chemical name Common trade names Mild Hydrocortisone 0.5%, 1.0%, 2.5% Hydrocortisone Dioderm®, Efcortelan®, Mildison® Moderate Betamethasone valerate 0.025% Betnovate-RD® Clobetasone butyrate 0.05% Eumovate®, Clobavate® Fluocinolone acetonide 0.001% Synalar 1 in 4 dilution® Fluocortolone 0.25% Ultralanum Plain® Fludroxycortide 0.0125% Haelan® Tape Strong Betamethasone valerate 0.1% Betnovate® Diflucortolone valerate 0.1% Nerisone® Fluocinolone acetonide 0.025% Synalar® Fluticasone propionate 0.05% Cutivate® Hydrocortisone butyrate 0.1% Locoid® Mometasone furoate 0.1% Elocon® Very strong Clobetasol propionate 0.1% Dermovate®, Clarelux® Diflucortolone valerate 0.3% Nerisone Forte® 1 of 5 In adults, stronger steroids are generally used on the body and mild or moderate steroids are used on the face and skin folds (armpits, breast folds, groin and genitals).
    [Show full text]
  • Download PDF File
    Folia Morphol. Vol. 79, No. 1, pp. 1–14 DOI: 10.5603/FM.a2019.0047 R E V I E W A R T I C L E Copyright © 2020 Via Medica ISSN 0015–5659 journals.viamedica.pl Should Terminologia Anatomica be revised and extended? A critical literature review P.P. Chmielewski1, B. Strzelec2, 3 1Division of Anatomy, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland 2Department and Clinic of Vascular, General and Transplantation Surgery, Jan Mikulicz-Radecki Medical University Hospital, Wroclaw Medical University, Wroclaw, Poland 3Department and Clinic of Gastrointestinal and General Surgery, Wroclaw Medical University, Wroclaw, Poland [Received: 14 November 2018; Accepted: 31 December 2018] The first edition of the Terminologia Anatomica was published in 1998 by the Federative Committee for Anatomical Terminology, whereas the second edition was issued in 2011 by the Federative International Programme for Anatomical Terminologies. Since then many attempts have been made to revise and extend the official terminology as several inconsistencies have been noted. Moreover, numerous crucial terms were either omitted or deliberately excluded from the official terminology, like sulcus popliteus and diaphragma urogenitale, respec- tively. Furthermore, several synonyms are to be discarded. Notwithstanding the criticism, the use of the current version of terminology is strongly recommended. Although the Terminologia Anatomica is open to future expansion and revision, every change should be made after a thorough discussion of the historical context and scientific legitimacy of a given term. The anatomical nomenclature must be as simple as possible but also precise and coherent. It is generally accepted that hasty innovation ought not to be endorsed.
    [Show full text]
  • Organ System % of Exam Content Diseases/Disorders
    Organ System % of Exam Diseases/Disorders Content Cardiovascular 16 Cardiomyopathy Congestive Heart Failure Vascular Disease Dilated Hypertension Acute rheumatic fever Hypertrophic Essential Aortic Restrictive Secondary aneurysm/dissection Conduction Disorders Malignant Arterial Atrial fibrillation/flutter Hypotension embolism/thrombosis Atrioventricular block Cardiogenic shock Chronic/acute arterial Bundle branch block Orthostasis/postural occlusion Paroxysmal supraventricular tachycardia Ischemic Heart Disease Giant cell arteritis Premature beats Acute myocardial infarction Peripheral vascular Ventricular tachycardia Angina pectoris disease Ventricular fibrillation/flutter • Stable Phlebitis/thrombophlebitis Congenital Heart Disease • Unstable Venous thrombosis Atrial septal defect • Prinzmetal's/variant Varicose veins Coarctation of aorta Valvular Disease Patent ductus arteriosus Aortic Tetralogy of Fallot stenosis/insufficiency Ventricular septal defect Mitral stenosis/insufficiency Mitral valve prolapse Tricuspid stenosis/insufficiency Pulmonary stenosis/insufficiency Other Forms of Heart Disease Acute and subacute bacterial endocarditis Acute pericarditis Cardiac tamponade Pericardial effusion Pulmonary 12 Infectious Disorders Neoplastic Disease Pulmonary Acute bronchitis Bronchogenic carcinoma Circulation Acute bronchiolitis Carcinoid tumors Pulmonary embolism Acute epiglottitis Metastatic tumors Pulmonary Pulmonary nodules hypertension Croup Obstructive Pulmonary Cor pulmonale Influenza Disease Restrictive Pertussis Asthma Pulmonary
    [Show full text]
  • Clinical Features and Histological Description of Tongue Lesions in a Large Northern Italian Population
    Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e560-5. Retrospective study on tongue lesions Journal section: Oral Medicine and Pathology doi:10.4317/medoral.20556 Publication Types: Research http://dx.doi.org/doi:10.4317/medoral.20556 Clinical features and histological description of tongue lesions in a large Northern Italian population Alessio Gambino 1, Mario Carbone 1, Paolo-Giacomo Arduino 1, Marco Carrozzo 2, Davide Conrotto 1, Carlotta Tanteri 1, Lucio Carbone 3, Alessandra Elia 1, Zaira Maragon 3, Roberto Broccoletti 1 1 Department of Surgical Sciences, Oral Medicine Section, CIR - Dental School, University of Turin, Turin, Italy 2 Oral Medicine Department, Centre for Oral Health Research, Newcastle University, Newcastle upon Tyne, UK 3 Private practice, Turin Correspondence: Oral Medicine Section University of Turin CIR – Dental School Gambino A, Carbone M, Arduino PG, Carrozzo M, Conrotto D, Tanteri Via Nizza 230, 10126 C, Carbone L, Elia A, Maragon Z, Broccoletti R. Clinical features and Turin, Italy histological description of tongue lesions in a lar�������������������������ge Northern Italian popu- [email protected] lation. Med Oral Patol Oral Cir Bucal. 2015 Sep 1;20 (5):e560-5. http://www.medicinaoral.com/medoralfree01/v20i5/medoralv20i5p560.pdf Article Number: 20556 http://www.medicinaoral.com/ Received: 21/12/2014 © Medicina Oral S. L. C.I.F. B 96689336 - pISSN 1698-4447 - eISSN: 1698-6946 Accepted: 25/04/2015 eMail: [email protected] Indexed in: Science Citation Index Expanded Journal Citation Reports Index Medicus, MEDLINE, PubMed Scopus, Embase and Emcare Indice Médico Español Abstract Background: Only few studies on tongue lesions considered sizable populations, and contemporary literature does not provide a valid report regarding the epidemiology of tongue lesions within the Italian population.
    [Show full text]
  • For Sexual Health Care of Clinical
    Clinical Guidelines for Sexual Health Care of Men Who Have Sex with Men Clinical ...for Sexual Health Care of IUSTI Asia Pacific Branch The Asia Pacific Branch of IUSTI is pleased to introduce a set of clinical guidelines for sexual health care of Men who have Sex with Men. This guideline consists of three types of materials as follows: 1. The Clinical Guidelines for Sexual Health Care of Men who Have Sex with Men (MSM) 2. 12 Patient information leaflets (Also made as annex of item 1 above) o Male Anogenital Anatomy o Gender Reassignment or Genital Surgery o Anogenital Ulcer o Genital Warts o What Infections Am I At Risk Of When Having Sex? o Hormone Therapy for Male To Female Transgender o How To Put On A Condom o Proctitis o What Can Happen To Me If I Am Raped? o Scrotal Swelling o What Does An STI & HIV Check Up Involve? o Urethral Discharge 3. Flip Charts for Clinical Management of Sexual Health Care of Men Who Have Sex with Men (Also made as an annex of item 1 above) The guidelines mentioned above were developed to assist the following health professionals in Asia and the Pacific in providing health care services for MSM: • Clinicians and HIV counselors who work in hospital outpatient departments, sexually transmitted infection (STI) clinics, non-government organizations, or private clinics. • HIV counselors and other health care workers, especially doctors, nurses and counselors who care for MSM. • Pharmacists, general hospital staff and traditional healers. If you would like hard copies of the set of clinical guidelines for sexual health care of Men who have Sex with Men, please contact Dr.
    [Show full text]